Fresenius Kabi Announces 340B Contract Pharmacy Restrictions, In-House Data Reqs
340B ReportTopic alignment 88
Germany-based Fresenius Kabi recently became the 45th drugmaker to announce 340B contract pharmacy restrictions and the 17th to announce in-house [...]
Filed under
- 340Bmatch 88
Jeff Davis Examines Potential Legal Challenges to New 340B Medicare Payment Rule
Bass BerryTopic alignment 92
Medicare will cut billions from 340B, expand site-neutral payments in 2027
MedTech DiveTopic alignment 95
Also covered by BioPharma Dive, Healthcare Dive
CY 2027 OPPS Final Rule: What the 340B Changes Mean for Hospitals, Patients, and Pharma
Turquoise Health (blog and reports)Topic alignment 94
2027 Medicare OPPS final rule cuts 340B payments, expands site-neutral rates
HFMATopic alignment 95